Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Obesity hypertension: differential central modulation of appetite, metabolism and cardiovascular homeostasis by leptin.

EF 2008-09

Résumé
High blood pressure (hypertension) is a major risk factor for stroke and heart disease. The leading cause of hypertension is excess weight gain (obesity). Over 22.7% of Canadians are obese, making obesity a national health and economic problem, with medical costs of $1.6 billion/year. Excess weight gain results in dangerous increases in blood pressure, but we know little about how this occurs. We know that (a) a hormone "leptin" controls blood pressure and (b) the kidney and its nerves are involved. Leptin is produced by fat cells, so blood leptin increases as body fat increases. Leptin acts on leptin receptors in the brain to reduce appetite and increase energy expenditure (metabolism) and blood pressure (via activation of nerve activity to the kidneys). In obesity, high leptin is present, but appetite is not suppressed and blood pressure continues to increase. We predict that leptin may act on one part of the brain to control appetite, while acting on others to control blood pressure and nerve activity. In obesity, the brain pathways for appetite control by leptin may not be functioning, leading to increased calorie intake and weight gain. In contrast, brain pathways for blood pressure control may be functional, resulting in dangerous increases in blood pressure. We propose experiments using different groups of mice that have been genetically engineered to lack leptin receptors in specific parts of the brain. By measuring blood pressure, food intake, physical activity and kidney nerve activity in these mice, we will determine which brain regions are important for producing the various effects of leptin. We expect the forebrain is important in controlling blood pressure and nerve activity, while the forebrain and hindbrain are key for appetite control by leptin. Understanding how leptin controls appetite and blood pressure will clarify the link between obesity and hypertension and is vital for prevention of complications and death due to obesity hypertension.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Mississippi, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
179699
Name
Hamza Shereen M
Region
Mississippi
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Obesity hypertension: differential central modulation of appetite, metabolism and cardiovascular homeostasis by leptin.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Central Nervous System; Chronic Surgery; Hypertension; Leptin; Metabolism; Nerve Recording; Obesity; Renal; Telemetry; Transgenic Mice
Abstract
High blood pressure (hypertension) is a major risk factor for stroke and heart disease. The leading cause of hypertension is excess weight gain (obesity). Over 22.7% of Canadians are obese, making obesity a national health and economic problem, with medical costs of $1.6 billion/year. Excess weight gain results in dangerous increases in blood pressure, but we know little about how this occurs. We know that (a) a hormone "leptin" controls blood pressure and (b) the kidney and its nerves are involved. Leptin is produced by fat cells, so blood leptin increases as body fat increases. Leptin acts on leptin receptors in the brain to reduce appetite and increase energy expenditure (metabolism) and blood pressure (via activation of nerve activity to the kidneys). In obesity, high leptin is present, but appetite is not suppressed and blood pressure continues to increase. We predict that leptin may act on one part of the brain to control appetite, while acting on others to control blood pressure and nerve activity. In obesity, the brain pathways for appetite control by leptin may not be functioning, leading to increased calorie intake and weight gain. In contrast, brain pathways for blood pressure control may be functional, resulting in dangerous increases in blood pressure. We propose experiments using different groups of mice that have been genetically engineered to lack leptin receptors in specific parts of the brain. By measuring blood pressure, food intake, physical activity and kidney nerve activity in these mice, we will determine which brain regions are important for producing the various effects of leptin. We expect the forebrain is important in controlling blood pressure and nerve activity, while the forebrain and hindbrain are key for appetite control by leptin. Understanding how leptin controls appetite and blood pressure will clarify the link between obesity and hypertension and is vital for prevention of complications and death due to obesity hypertension.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hamza, Shereen M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~